LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.

Huang R-Y, Eppolito C, Lele S, Shrikant P, Matsuzaki J, Odunsi K. "LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model." Oncotarget. 2015;6(29):27359-77.